UnitedHealth Group continues to demonstrate strong market resilience. Our proprietary Credit Memo model indicates robust fundamentals despite macroeconomic headwinds. Key catalysts include product innovation in AI and strategic cost optimization.
We utilize a blended approach of DCF (50%) and EV/EBITDA multiples (50%). Our WACC assumption is 9.1% based on a beta of 1.17.